MedTrace Logo

Screening for Vulnerability in the Elderly Supported at the Oscar Lambret Centre

NCT01415258 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 209

Last updated 2026-03-16

No results posted yet for this study

Summary

The objective of this study is to uncover the prevalence of vulnerability among patients aged ≥ 70 coming to the medical oncology division of the Oscar Lambret Centre, according to the short screening test Vulnerable Elders Survey 13 (VES-13).

The objective is to better understand the value of routine screening of patients before the consultation, it was proposed as a secondary objective of this study to assess the correlation between the identification of the vulnerability in the screening test VES-13 and the identification made by the clinician during the consultation. The correlation between VES-13 and opinion of the clinician for three categories of patients (self - intermediate - fragile) will also be studied.

Conditions

Sponsors & Collaborators

  • Hôpital Gériatrique Les Bateliers, CHRU Lille

    collaborator UNKNOWN

  • Centre Oscar Lambret

    lead OTHER

Principal Investigators

  • Véronique SERVENT, MD · Oscar Lambret Anti-Cancer Centre

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-03-31
Primary Completion
2011-08-31
Completion
2012-04-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01415258 on ClinicalTrials.gov